ArticleGynecologic oncology2023

The Poly (ADP-ribose) polymerase inhibitor olaparib and pan-ErbB inhibitor neratinib are highly synergistic in HER2 overexpressing epithelial ovarian carcinoma in vitro and in vivo.

Chanhee Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.